SPOTLIGHT -
Novartis sponsored a symposium at the COPHy congress in 2012 exploring the current treatment issues surrounding wet AMD. This supplement reveals the highlights of the meeting.
Going beyond the clinical setting in ophthalmic mentorship
Three leaders in glaucoma research, retina care and refractive surgery share their expertise
Updates From Angiogenesis-2022
ARVO 2024: Diabetic retinopathy risk factors in paediatric patients with Type 1 diabetes
Study results indicate that maintaining control of blood pressure and hemoglobin A1c are key to preventing the onset of diabetic retinopathy
Updates from ASRS 2021
Espansione Group: Illuminating the Future of AMD Treatment: The Breakthrough of LightWave I Trial with PBM Technology
Data from self-tonometry supports glaucoma treatment decisions